Jones’ most recent health-tech triumph came as the primary designer of AllazoHealth’s AllazoEngine, an AI platform created to optimize medication adherence programs and achieve greater prescription refills at lower costs. In conjunction with pharma and biotech companies, the AllazoEngine runs thousands of algorithms to predict which patients will become non-adherent, then selects the type of intervention to which the patient is likely to respond. The results have spoken for themselves: While non-adherence is still considered an expensive cost of everyday business, the AllazoEngine is helping organizations reduce unnecessary spending on interventions and simultaneously achieving greater prescription refills.